5.0
19 Aug 2021
Current employee, more than 5 years
Washington, DC
Recommend
CEO approval
Business outlook
Pros
Inclusive culture, no grant writing, access to state-of-the-art facilities for research
Cons
It is more difficult to transition to industry than from a university or FDA